CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-01-06 | KELER TIBOR Sr. VP & CSO | Grant or award | +5,868 | 5,868 | ||
| 2009-01-06 | KELER TIBOR Sr. VP & CSO | Grant or award · Incentive Stock Option | +72,250 | $8.52 | $616K | 72,250 |
| 2009-01-06 | Davis Thomas Andrew Sr. VP & CMO | Grant or award | +5,868 | 5,868 | ||
| 2009-01-06 | Davis Thomas Andrew Sr. VP & CMO | Grant or award · Incentive Stock Option | +76,400 | $8.52 | $651K | 76,400 |
| 2009-01-06 | Marucci Anthony S President & CEO | Grant or award | +5,868 | 5,868 | ||
| 2009-01-06 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option | +129,000 | $8.52 | $1.1M | 129,000 |
| 2009-01-02 | CATLIN AVERY W Sr. VP & CFO | Other acquisition | +100 | $6.73 | $673 | 100 |
| 2008-11-13 | SCHALLER CHARLES R Director | Purchase | +3,000 | $6.11 | $18K | 3,000 |
| 2008-09-25 | ELLBERGER LARRY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | Elston George Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | LIPTON KAREN SHOOS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | PAREKH RAJESH R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-25 | SCHALLER CHARLES R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2008-09-10 | PAREKH RAJESH R Director | Sale | −2,178 | $11.00 | $24K | 0 |
| 2008-09-09 | PAREKH RAJESH R Director | Sale | −25,770 | $11.05 | $285K | 2,178 |
| 2008-09-08 | PAREKH RAJESH R Director | Sale | −28,275 | $11.37 | $322K | 27,948 |
| 2008-06-23 | MEDAREX INC 10% owner | Sale | −351,691 | $12.35 | $4.3M | 4,960,848 |
| 2008-04-07 | Lorantis Holdings LTD 10% owner | Other disposition | −2,811,147 | 0 |
Page 30 of 32 · 629 trades